Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-22-000020

EVP, Chief Financial Officer gave up 2,298 shares (to pay taxes)

  • EVP, Chief Financial Officer acquired 1,836 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-22 Grant or award : show line 1 in the form +1,836 41,755 D
2022-02-22 Shares withheld for taxes : show line 2 in the form −2,298 $42.23 $97,045 39,457 D
Loading xslF345X03/wf-form4_164574681773856.xml…